Hoosier Cancer Research Network Welcomes New Chairman
Hoosier Oncology Group is very pleased to announce that Christopher A. Fausel, PharmD, MHA, BCOP, was appointed Chairman of the Board of Directors on July […]
Hoosier Oncology Group is very pleased to announce that Christopher A. Fausel, PharmD, MHA, BCOP, was appointed Chairman of the Board of Directors on July […]
Investigators participating in Hoosier Cancer Research Network’s Thoracic Clinical Trial Working Group have named three of their colleagues to serve as co-chairs of the group. […]
2014 was a year of rapid fire change and accomplishment for the Hoosier Cancer Research Network (HCRN). It’s all in a name … the Hoosier […]
Angela Alistar, MD, has long considered both the emotional and physical well-being of patients as mutually paramount. A medical oncologist with Atlantic Hematology Oncology, Atlantic […]
The Bladder Cancer Advocacy Network (BCAN) and Paradigm today announced a partnership for the launch of a large-scale genomically-driven bladder cancer study. Hoosier Cancer Research […]
A Hoosier Cancer Research Network multi-site phase II study led by Icahn School of Medicine at Mount Sinai/Tisch Cancer Institute is testing the poly (ADP-ribose) […]
This month, Hoosier Cancer Research Network features our member, the University of Wisconsin Carbone Cancer Center, and Christos Kyriakopoulos, MD, associate professor of medicine at […]
This month, Hoosier Cancer Research Network features our member institution The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard […]
Noah Hahn, MD, recently concluded his tenure as chief scientific officer of the Hoosier Oncology Group and associate professor of medicine at the Indiana University […]
Indiana University School of Medicine researchers have discovered how to predict whether triple negative breast cancer will recur, and which women are likely to remain […]
Around six years ago, Stephen Glick was a businessman, a manager of supply chains in manufacturing. Today, he is a regulatory affairs specialist at IU […]
Serving others has been a lifetime calling for Cara Ellis. As a child, her parents taught her to appreciate what she had and to make […]
Meet Hatim Sabaawy, MD, PhD Hatim Sabaawy, MD, PhD, of the University of Colorado Cancer Center is the Director of Personalized Medicine in the Division […]
Next Meeting See HCRN Calendar for schedule. Working Group Members Timothy Kuzel, MD (co-chair) — Northwestern University Suthee Rapisuwon, MD (co-chair) — Georgetown University Alan […]
OncoGenex Pharmaceuticals, Inc., recently announced that Borealis-2™, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen […]
A Phase II Study of Cisplatin, 5-Fluorouracil (5-FU), Radiation Therapy and Celecoxib for Resectable Esophageal Cancer – HOG GI 00-16
Columbus North High School in Columbus, Ind., will host the 2014 Courage to Climb concert on Saturday, Aug. 16, at 7:00 pm in Erne Auditorium. […]
Families who fight cancer along with their ailing loved one grapple with many issues, from health decisions and a myriad of emotions to logistical and […]
More than 30 years ago, a group of academic and community physicians in Indiana launched the Hoosier Oncology Group (or the “HOG”) as a new […]
Hoosier Cancer Research Network (HCRN) is currently seeking a part-time communications intern. Students working toward a college degree in Marketing/Communications, Advertising, Public Relations or English […]
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter